2022 Program Summary
It is an exciting time in the field of allergy and immunology. This CME/CEU program is designed to allow attendees to continue exploring the field. Covered topics include oral food challenges and novel food allergy therapies, contact dermatitis, chronic cough, asthma and biologics, and more!
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership the American College of Allergy, Asthma and Immunology and the California Society for Allergy, Asthma and Immunology. The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.
In compliance with the Americans with Disabilities Act, CSAAI requests that any participant in need of accommodation send an email to: [email protected]
AMA Credit Designation Statement
AMA Credit Designation Statement: The American College of Allergy, Asthma & Immunology designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
CE Designation: The American College of Allergy, Asthma & Immunology (ACAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 10.50 Contact Hours.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the California Society of Allergy, Asthma, and Immunology (CSAAI). The American College of Allergy, Asthma, and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by commercial interests
Cultural and Linguistic Competency - California AB 1195
This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities address cultural and linguistic competency in patient care delivery to meet the concerns of a diverse population through effective and appropriate professional development.
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewer, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company. The ACCME defines an “ineligible company” (formerly commercial interest) as a company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Examples of ineligible companies include: Advertising, marketing, or communication firms whose clients are ineligible companies; bio-medical startups that have begun a governmental regulatory approval process; compounding pharmacies that manufacture proprietary compounds; device manufacturers or distributors; diagnostic labs that sell proprietary products; growers, distributors, manufacturers or sellers of medical foods and dietary supplements; manufacturers of health-related wearable products; pharmaceutical companies or distributors; pharmacy benefit managers; reagent manufacturers or sellers). For more information, visit www.accme.org.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.
Current guidelines state that participants in continuing medical education activities should be aware of any affiliation or financial interest that could affect the speaker’s presentation(s). Faculty members have completed conflict of interest declarations and those potential conflicts will be listed in the course syllabus.
The Board of Directors of the California Society of Allergy, Asthma, and Immunology (WSAAI) serves as the Planning Committee for the Educational Meeting. The Board includes the following physicians: Marilyn Li, MD; Madeleine Ramos, MD; LanAnh Do, MD; Barbara Ariue, MD; Raffi Tachdjian, MD; Sonal Patel, MD; Javed Sheikh, MD; Myngoc Nguyen, MD; Vince Tubiolo, MD; Steven Meltzer, MD
At the conclusion of the conference, participants should be able to:
- Contact Dermatitis:
- Discuss various presentations of contact dermatitis
- Discuss the role of patch testing and practical aspects of emerging and important allergens
- Discuss rashes seen in the allergy office but aren’t allergic
- Discuss some differentiating features of eczematous diseases
- Food Allergy:
- Select appropriate patients for oral food challenge
- Identify safety precautions necessary for conducting oral food challenge
- Describe recent advances in OIT, SLIT and EPIT
- Identify advantages and disadvantages of all methods of treatment
- Discuss advances, expectations and limitations with your food allergic patients
- Evaluate and select evolving therapeutic strategies
- Review mechanisms, current bioloigics and effects
- Evaluate current clinical data indicating suggesting possible remittive effects of biologics in asthma
- Chronic Cough:
- Understand the differential diagnosis of cough and its potential causes;
- Undertake an evaluation through the anatomic diagnostic protocol;
- Treatment of the causes of chronic cough
- Define the criteria for diagnosis of MCAS
- Determine MCAS from other conditions presenting with a high serum tryptase (i.e. hereditary alpha-tryptasemia and systemic mastocytosis)
- Discuss treatment options for these patients to reduce morbidity and improve their quality of life
Industry-led lectures and exhibits will be conducted as optional learning opportunities in conjunction with this event. These optional activities are not certified for CME credit and are not planned or sanctioned by the American College of Allergy, Asthma, and Immunology or CSAAI.
1:00 pm: Registration and Exhibits
2:50 pm: Overview and Welcome (Marilyn Li, MD, President CSAAI)
Friday Practice Management Symposium featuring Dr. Anil Nanda and Dr. Warner Carr is brought to you by the California Society of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology
3:00 pm: Physician Wellness in Allergy and Immunology (Anil Nanda, MD)
4:00 pm: Top Allergy Papers
5:00 pm: Town Hall Meeting - Patient Advocacy (Warner Carr, MD, J. Kevin Pedrotti, Clear Advocacy, CSAAI Lobbyist)
6:00 pm: Adjourn
6:10 pm: Reception
7:00 am: Exhibits
8:00 am: Welcome & Overview (LanAnh Do, MD, Program Director)
8:10 am: Rashes that Look Like Allergies but Aren’t (Luz Fonacier, MD)
8:50 am: Is the Proof in the Pudding? Update on Novel Food Allergy Therapies (J. Andrew Bird, MD)
9:30 am: Updates on the Drug Allergy Practice Parameters (Kimberly G. Blumenthal, MD)
10:10 am: Panel Discussion/Q&A
10:30 am: Break and Exhibits
10:50 am: Hormonal and Seminal Sensitivity (Jonathan Bernstein, MD)
11:30 am: Approach to Chronic Cough (John Oppenheimer, MD)
12:10 pm: Contact Dermatitis for the Allergist (Luz Fonacier, MD)
12:50 pm: Panel Discussion/Q&A
1:05 pm: Adjourn
6:30 am: Annual Business Meeting Breakfast
7:00 am: Break & Exhibits
8:00 am: Overview (Barbara Ariue, MD, Executive Director)
8:10 am: Adverse Reactions to COVID-19 Vaccines (Kimberly G. Blumenthal, MD)
8:50 am: Biologics, Choosing Wisely (John Oppenheimer, MD)
9:30 am: Panel Discussion/Q&A
9:45 am: Break & Exhibits
10:00 am: Safely Conducting Oral Food Challenges in Practice (J. Andrew Bird, MD)
10:40 am: Is It Mast Cell Activation Syndrome? (Jonathan Bernstein, MD)
11:20 am: Panel Discussion/Q&A
11:30 am: Closing Remarks (Marilyn Li, MD, President CSAAI)
11:45: am: Adjourn
The CSAAI has assembled a world-class faculty for the 2022 Annual Meeting.
Jonathan Bernstein, MD
Hormonal and Seminal Sensitivity
Is It Mast Cell Activation Syndrome?
J. Andrew Bird, MD
Is the Proof in the Pudding? Update on Novel Food Allergy Therapies
Safely Conducting Oral Food Challenges in Practice
Kimberly G. Blumenthal, MD
Updates on the Drug Allergy Practice
Adverse Reactions to COVID-19 Vaccines
Warner Carr, MD
Luz Fonacier, MD
Rashes that Look Like Allergies but Aren’t
Contact Dermatitis for the Allergist
Anil Nanda, MD
Physician Wellness in Allergy and Immunology
John Oppenheimer, MD
Approach to Chronic Cough
Biologics, Choosing Wisely
Kevin Pedrotti, MD
Town Hall Meeting